Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-02

Clinical Trial Update: Targeting the Endothelial Glycocalyx to Enhance Vascular Function and Exercise-Induced Vascular Adaptations in Type 2 Diabetes [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update summarizes Phase 2 and Phase 3 results evaluating strategies to target the endothelial glycocalyx to improve vascular function and ex…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: VA Office of Research and Development | Conditions: Diabetes Mellitus, Type 2 | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2025-04-02